1. Home
  2. SOBR vs PRFX Comparison

SOBR vs PRFX Comparison

Compare SOBR & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SOBR Safe Inc.

SOBR

SOBR Safe Inc.

HOLD

Current Price

$0.90

Market Cap

2.4M

ML Signal

HOLD

Logo PainReform Ltd.

PRFX

PainReform Ltd.

HOLD

Current Price

$1.65

Market Cap

2.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOBR
PRFX
Founded
2004
2007
Country
United States
Israel
Employees
N/A
N/A
Industry
Newspapers/Magazines
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4M
2.6M
IPO Year
2008
2020

Fundamental Metrics

Financial Performance
Metric
SOBR
PRFX
Price
$0.90
$1.65
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
191.0K
4.0M
Earning Date
04-10-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
103.55
N/A
EPS
N/A
N/A
Revenue
$437,421.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
105.62
N/A
52 Week Low
$0.48
$0.58
52 Week High
$5.27
$5.39

Technical Indicators

Market Signals
Indicator
SOBR
PRFX
Relative Strength Index (RSI) 43.78 48.08
Support Level $0.69 $1.00
Resistance Level $1.03 $2.89
Average True Range (ATR) 0.12 0.43
MACD -0.03 0.03
Stochastic Oscillator 31.30 12.26

Price Performance

Historical Comparison
SOBR
PRFX

About SOBR SOBR Safe Inc.

Sobr Safe Inc is a hardware and software company. The Company integrates proprietary software, SOBRsafeTM, with its patented touch-based personal alcohol awareness tracking products, SOBRcheckTM and SOBRsure, enabling non-invasive personal alcohol awareness tracking, biometric identity verification, and qualified, real-time cloud-based, informational alerts and reporting. It operates as a single segment designed to enable customers to purchase products directly through channel partners, sales agents or through its enterprise and consumer digital channels. Currently its principal markets are located in North America.

About PRFX PainReform Ltd.

PRF Technologies Ltd is a a diversified platform spanning speciality pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. PRF Technologies focuses on pharmaceutical therapies that emphasize reformulation and sustained-release drug-delivery technologies and AI-driven energy analytics. PRF-110, the company's lead product, is based on the local anesthetic ropivacaine and targets the postoperative pain relief market. The company has two operating segments composed of the Clinical Development segment, which facilitates the development of potential new drug compounds, and the Solar segment, which comprises the design and development of the company's intellectual property and the sale related service offerings.

Share on Social Networks: